Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Noa Ephrat Ben‐Baruch"'
Autor:
Yael, Laitman, Rachel, Michaelson-Cohen, Rakefet, Chen-Shtoyerman, Yael, Goldberg, Orit, Reish, Rinat, Bernstein-Molho, Ephrat, Levy-Lahad, Noa Ephrat Ben, Baruch, Inbal, Kedar, D Gareth, Evans, Sara, Haim, Shani, Paluch-Shimon, Eitan, Friedman
Publikováno v:
Familial cancer. 20(3)
Germline pathogenic sequence variants (PSVs) in BRCA1 substantially increase risk for developing breast (BC) and ovarian cancer (OvC). Yet, incomplete penetrance suggests that modifier factors affect phenotypic expression of mutant BRCA1 alleles. Ana
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::743b26b3edac48b60cc8cb063876bc7a
https://pubmed.ncbi.nlm.nih.gov/33165727
https://pubmed.ncbi.nlm.nih.gov/33165727
Autor:
Noa Ephrat Ben‐Baruch, Rakefet Chen-Shtoyerman, Ephrat Levy Lahad, Pnina Mor, Jacob Korach, Rinat Bernstein-Molho, Sagi Josefsberg Ben-Yehoshua, Rachel Michaelson-Cohen, Lital Keinan-Boker, Tamar Perri, Orit Reish, Yael Laitman, Einat Levi, Ora Rosengarten, Barbara Silverman, Eitan Friedman
Publikováno v:
Cancer. 125:698-703
BACKGROUND BRCA1/2 mutation carriers have an increased risk of developing ovarian cancer, leading to the recommendation of risk-reducing salpingo-oophorectomy (RRSO) at 35-40 years of age. The role, if any, that BRCA mutations play in conferring uter
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a4c0d894792a73cbbbdabd126bdcc06d
https://doi.org/10.1002/cncr.31842
https://doi.org/10.1002/cncr.31842